AVE 0.00% 0.2¢ avecho biotechnology limited

marketing is the key to poh growth, page-25

  1. 5,322 Posts.
    A very fair summary Dougal......except for the bit about POH being cash strapped. Strictly speaking most companies are cash strapped in that they don't have the spare funds to cover all of their investment, growth, new product, marketing ,capex and other wish list requirements at any one time. So they develop business plans and work out how to cash flow these plans with what funds they have on hand and expect to generate. POH has such a plan and expects to be cash positive next yr. This is their business plan which is approved by a Board with substantial commercial experience. With such a rich Drug pipeline and diversified drug delivery platform ....this co will always be able to raise funds if and when they are required. What we all are hopeful is that the personal care product rollout flagshipped by Body Shaper will ensure POH has the funding necessary to advance POHs lead drug candidates to a point where a partner deal can be struck with up fronts and milestones.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
0.000(0.00%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.2¢ 0.2¢ 0.2¢ $240 120K

Buyers (Bids)

No. Vol. Price($)
50 43820232 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 43900696 24
View Market Depth
Last trade - 10.00am 12/09/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.